May 3, 2024
“Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer, pending approval of the claimants. Those cases… Continue Reading…
April 25, 2024
“Tesla’s loss of $328.3 billion this year in stock value certainly hurts. But it’s amazingly only the second-largest market value loss in the S&P 500. The dubious distinction of shredding the most value this year goes to Apple (AAPL). The Johnny-come-lately to AI’s… Continue Reading…
April 17, 2024
“…Apple’s decision to overhaul its Mac computer line to focus on artificial intelligence, as reported by Bloomberg, struck a chord with investors, sending the stock up 4.3% and adding $112 billion in value in its best performance in nearly a… Continue Reading…
April 16, 2024
“Vertex Pharmaceuticals VRTX -0.02%decrease; red down pointing triangle has agreed to acquire Alpine Immune Sciences ALPN -0.01%decrease; red down pointing triangle for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up. The companies said Wednesday that Vertex would… Continue Reading…
April 16, 2024
“… …” https://www.cnbc.com/2024/04/10/forever-chemical-pfas-pfos-regulation-to-cost-1point5-billion-annually-.html This is one time the cost is worth it. The alternative is cancer causing chemicals. No thanks.
April 10, 2024
“April 9 (Reuters) – Israel’s data security firm Cyera has tripled its valuation to $1.4 billion in less than a year as it raised fresh capital in a series C funding led by U.S. tech-focused fund Coatue Management… The rapid… Continue Reading…
April 9, 2024
“…The company just announced its biggest acquisition ever, taking over SRS Distribution for $18.25 billion, including SRS’s debt. Home Depot said the deal would expand its addressable market by around $50 billion, and CEO Ted Decker called SRS “An industry… Continue Reading…
April 8, 2024
“Johnson & Johnson on Friday agreed to buy Shockwave Medical for $12.5 billion in a deal that would help broaden its portfolio of medical devices used in treating heart diseases. The acquisition gives J&J access to a device that uses shockwaves to break… Continue Reading…
Recent Comments